What impact will ICER reports have in Europe? Should value frameworks for rare disease be different? How is the current uncertainty in healthcare affecting you? Could your advisory board benefit from a medical writer? Read more about all of these topics and more in HealthEconomics.Com’s latest newsletter. If you would like to sign up and receive our weekly newsletter in your inbox, sign up here.
Connected. Community.
